Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julie Rich Ingelfinger, M.D.

Concepts (995)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Julie Ingelfinger's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Julie Ingelfinger has written about over time.
Hematuria, 4 publications between 1970 and 2021, average publication date October 1997. Angiotensinogen, 45 publications between 1986 and 2021, average publication date May 2001. Angiotensin II, 23 publications between 1989 and 2022, average publication date August 2002. Renin-Angiotensin System, 40 publications between 1982 and 2022, average publication date September 2002. Kidney, 78 publications between 1971 and 2023, average publication date October 2003. Antihypertensive Agents, 14 publications between 1993 and 2014, average publication date February 2004. Kidney Tubules, Proximal, 55 publications between 1990 and 2021, average publication date July 2005. Blood Pressure, 39 publications between 1982 and 2024, average publication date January 2006. Thromboplastin, 8 publications between 1999 and 2015, average publication date July 2006. Hypertension, 65 publications between 1980 and 2024, average publication date August 2007. Kidney Diseases, 44 publications between 1972 and 2024, average publication date October 2008. Angiotensin II Type 1 Receptor Blockers, 9 publications between 2004 and 2014, average publication date December 2008. Glomerulosclerosis, Focal Segmental, 5 publications between 1983 and 2023, average publication date September 2011. Acute Kidney Injury, 14 publications between 1999 and 2021, average publication date February 2013. Diabetic Nephropathies, 18 publications between 2006 and 2021, average publication date October 2013. Renal Insufficiency, Chronic, 24 publications between 2006 and 2023, average publication date November 2015. Health Promotion, 8 publications between 2016 and 2016, average publication date February 2016. Glucagon-Like Peptides, 2 publications between 2021 and 2021, average publication date April 2021.

To see the data from this visualization as text, click here.
Ingelfinger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (995)
Explore
_
Co-Authors (48)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.